ESR1 and breast cancer: Although no significant correlation was observed between MIR3613 copy number and survival in the whole cohort or ER negative subset of breast cancer patients (Supplementary Fig. 1B), deletion of MIR3613 was associated with an unfavorable prognosis in the ER positive patients (Fig. 1d).